The identification of variants in well-established genes, such as PNPLA3, SAMM50, and TM6SF2, underscores the role of genetic predisposition in the development of MASLD in normal-weight individuals. The gene discussed is SAMM50; the disease is metabolic dysfunction-associated steatotic liver disease.